Approval of Edurant (Rilpivirine), a New NNRTI, for the Treatment of HIV in Treatment Naive Patients - The Body
Links shared publicly online about this topic.
- 279total visits
Approval of Edurant (Rilpivirine), a New NNRTI, for the Treatment of HIV in Treatment Naive Patients - The Body
On Friday, May 20, 2011, FDA approved Edurant (rilpivirine) 25 mg tablets, a new non-nucleoside reverse transcriptase inhibitor (NNRTI) for the treatment ...
View full resource at thebody.com
Most Recently Shared on May 20, 2011 at 7:26 pm By:
Here's the official FDA approval notice on Edurant (rilpivirine), the first new NNRTI for HIV treatment since 2008: http://bit.ly/iHbHD1
Advertisement
